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COMPARING MEDICAL PROVIDERS: WHAT DO
STATISTICS TELL US AND HOW SHOULD THEY
BE USED?
FOREWORD
For many years information has been available concerning
the possible adverse effects of various medical procedures on a
particular patient's diagnosis. This information has obvious uses
in medical decision making and, when not offered to patients,
has often provided the basis for informed consent litigation. Un-
til recently, however, quantified information as to the possibility
of adverse effects for a given procedure provided by a particular
physician or hospital was not available. In 1990 the New York
State Department of Health began to release to the public de-
tailed information about the comparative risk of open heart sur-
gery at different hospitals. The Department of Health study not
only compiled raw mortality data for the various hospitals on
open heart surgery, but also, using a complex statistical model,
provided a risk-adjusted mortality rate for each hospital that
controlled for over twenty variables which could affect patient
mortality. Use of the model has already been expanded to mea-
sure the risk factors of individual doctors and the model soon
will be applied to other procedures.
The availability for the first time of such provider-specific
statistical data is certain to have a profound impact on law and
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medicine. This issue of the Brooklyn Law Review includes arti-
cles that emerged from Brooklyn Law School's 1992 Symposium
on Comparing Medical Providers: What Do Statistics Tell Us
and How Should They Be Used?
On the legal side, Professors Aaron D. Twerski, J.D., and
Neil B. Cohen, J.D., of Brooklyn Law School note in their arti-
cle, Comparing Medical Providers: A First Look At The New
Era of Medical Statistics, that since the number and sophistica-
tion of such comparative statistical studies will only increase
over time, the issue to be addressed is whether, and to what ex-
tent, these statistical studies pose problems when they are used
in negligence and informed consent claims. The authors are pre-
pared to recognize a new cause of action in negligence. Under
certain circumstances, they argue that a provider's decision to
perform a procedure at which she is substantially less skillful
than the relevant market itself constitutes negligence. This new
cause of action is distinct from whether the procedure was per-
formed negligently. In so doing, the authors explore ways the
legal system can compare the actual injury resulting from the
negligent act of performing the procedure with the injury that
might, or might not, have occurred if an alternative provider had
performed the procedure. Twerski and Cohen ultimately argue
that patients are entitled to partial recovery based on the de-
creased chance of a successful procedure brought about by the
provider's deficient skill, despite some statistical pitfalls.
In addition, the authors foresee a new cause of action in in-
formed consent for a provider's failure to disclose to a patient
these available, although currently imperfect, data. At the same
time, the authors acknowledge the potential problems spawned
by this new cause of action. In particular, the disclosure of these
data to patients by providers may drive providers with
"bad"-albeit flawed-statistical profiles out of the market.
The authors recognize that whether a provider is "bad"
enough to warrant sanctions on either a negligence or an in-
formed consent theory will require a finding that the deviation
from whatever norm is chosen is statistically significant and of
sufficient magnitude to demand legal recognition. This will re-
quire courts to evaluate carefully the statistics to determine
whether both statistical significance and overall performance are
so important that the law ought to take them into account.
These new informed consent claims have the potential to change
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the health care delivery system dramatically.
Paul D. Rheingold, J.D., a leading plaintiff's attorney in
products liability, medical malpractice and drug-related litiga-
tion, examines in his article, The Admissibility of Evidence in
Malpractice Cases: The Performance Records of Practitioners,
how the availability of mortality and morbidity statistics of spe-
cific hospitals and practitioners may be used in medical mal-
practice litigation. He concludes that the goal of improving the
quality of health care will not necessarily be furthered, and may
be frustrated, if performance data are allowed into court as some
evidence in malpractice actions of the doctor's good or bad per-
formance. Nonetheless, he argues that these performance statis-
tics should be revealed because a doctor has a duty to disclose
" what is known about treatment risks and failure to do so consti-
tutes a breach of that duty.
On the health care side, Jesse Green, Ph.D., contends in his
article, Problems in the Use of Outcome Statistics to Compare
Health Care Providers, that while research into effectiveness of
care should continue, premature use of the early fruit of such
research raises the specter of misinforming health care consum-
ers. Green examines the scientific basis on which such outcome
studies rest and explores some of the pressing concerns about
their validity. In particular, he finds that mortality statistics
may be biased against some providers that offer excellent care to
very high-risk patients. In addition, some of the databases used
for analyzing provider outcomes fail to meet scientific standards
of accuracy and completeness. He concludes that provider-spe-
cific outcome statistics must be carefully evaluated for reliability
and validity whenever they are used as evidence in court.
Mark V. Pauly, Ph.D., Benheim Professor at the Wharton
School of Business, University of Pennsylvania, approaches the
rise and use of outcome studies somewhat differently, looking at
the era of outcomes measurement within the context of the
movement to contain costs in health care delivery. In his article,
The Public Policy Implications of Using Outcome Statistics,
Pauly argues that although statistical measurements are intrinsi-
cally imperfect in measuring health outcomes, public policy will
continue to demand their use. How these measures will be used
depends on the rest of the health care delivery and financing
system. In the end, he suggests that outcome statistics will have
a significant impact on the economics of health care delivery.
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Patients, as consumers and voters, increasingly will be making
choices based on these statistics.
This series of articles is a preview of the potential effect of
outcome statistics on medical care, legal practice and public pol-
icy. We hope these pieces will spur further scholarship in this
new and potentially transforming area of the law.
The Editors
